Mark Bachleda - Chief Commercial Officer at Galera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
GRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Bachleda since 7/7/2023

Holdings reported by Mark Bachleda for Galera Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 11,000 $24.7 K $2.25 Mar 16, 2023 Direct
Stock Option (Right to Buy) 135,000 Feb 25, 2023 Direct Common Stock

Transactions reported by Mark Bachleda for Galera Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership